We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SEC Proposed Whistle-Blower Rule Expected to Impact Drugmakers
SEC Proposed Whistle-Blower Rule Expected to Impact Drugmakers
November 5, 2010
In a move with implications for drugmakers, the SEC has proposed a new whistle-blower program that describes the procedures for individuals to follow in providing tips that lead to enforcement action.